Back to Home
Live Event

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

October 2-3, 2026

Overview

Physicians’ Education Resource®, LLC (PER®), is pleased to present the 2026 International Symposium of Gastrointestinal Oncology® (ISGIO), a 2-day, multidisciplinary educational conference dedicated to presenting and discussing the latest advances in the broad field of gastrointestinal (GI) cancer research, as well as critical issues relevant to the care of persons with GI cancer.

Management of GI malignancies has evolved across all disciplines, from screening to prognostication to treatment approaches of all modalities. However, many patients do not fall neatly into guideline-based treatment, and the volume of clinical trial data makes it difficult to parse findings that should inform treatment.

This highly engaging conference brings together world-renowned experts from different disciplines to educate clinicians using a combination of case-based learning, debates, and panel discussions. This dynamic, multi-format program is designed to be a comprehensive review of the emerging treatment landscape for GI cancers, with the goal of elucidating the complex array of recent studies that should inform clinician practice.

Program Co-Chairs

Tanios Bekaii-Saab, MD; Eileen M. O’Reilly, MD, FASCO

To view full profile, click on the Program Co-Chairs tab above.

Event Details

  • Start Date
    October 2, 2026
  • End Date
    October 3, 2026
  • Location
    Fort Lauderdale, FL
  • Venue
    W Fort Lauderdale
    401 North Fort Lauderdale Beach Boulevard
    Fort Lauderdale, FL 33304
    View Accommodations
  • Target Audience
    This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in GI oncology. Other health care professionals interested in the treatment of these malignancies are also invited to participate.

This activity is supported by an educational grant from Partner Therapeutics, Inc.

PER is proud to partner with the GI Cancers Alliance (GICA).

Follow Us on Social Media!

Related Content